ML
Miles Linde
Fred Hutch Cancer Center, Stanford University
Research areas: Immunology and Microbiology · Immunology · Immunotherapy and Immune Responses · Cancer Immunotherapy and Biomarkers · T-cell and B-cell Immunology
0000-0003-2553-2890
Employment
-
Fred Hutchinson Cancer Center Postdoctoral Fellow2022 - Present
-
Stanford University School of Medicine Graduate Student2015 - 2022
Education
Education history is unavailable.
Projects & Funding
-
Mapping Immune Dependencies of Disseminated Tumor Cells within the Bone Marrow American Cancer Society2025 - 2028
Publications (114)
- Modulating AP-1 enables CAR T cells to establish an intratumoral stemlike reservoir and overcomes resistance to PD-1 blockade Save
- Single cell multi-omics enables high-resolution identification and functionalpurification of human acute myeloid leukemia stem cells Save
- Data from Reprogramming Cancer into Antigen-Presenting Cells as a Novel Immunotherapy Save
- Supplemental Figure S1 from Reprogramming Cancer into Antigen-Presenting Cells as a Novel Immunotherapy Save
- Supplemental Figure S10 from Reprogramming Cancer into Antigen-Presenting Cells as a Novel Immunotherapy Save
- Supplemental Figure S2 from Reprogramming Cancer into Antigen-Presenting Cells as a Novel Immunotherapy Save
- Supplemental Figure S3 from Reprogramming Cancer into Antigen-Presenting Cells as a Novel Immunotherapy Save
- Supplemental Figure S4 from Reprogramming Cancer into Antigen-Presenting Cells as a Novel Immunotherapy Save
- Supplemental Figure S5 from Reprogramming Cancer into Antigen-Presenting Cells as a Novel Immunotherapy Save
- Supplemental Figure S6 from Reprogramming Cancer into Antigen-Presenting Cells as a Novel Immunotherapy Save
- Supplemental Figure S7 from Reprogramming Cancer into Antigen-Presenting Cells as a Novel Immunotherapy Save
- Supplemental Figure S8 from Reprogramming Cancer into Antigen-Presenting Cells as a Novel Immunotherapy Save
- Supplemental Figure S9 from Reprogramming Cancer into Antigen-Presenting Cells as a Novel Immunotherapy Save
- Supplemental Table 1 from Reprogramming Cancer into Antigen-Presenting Cells as a Novel Immunotherapy Save
- A single-cell framework identifies functionally and molecularly distinct multipotent progenitors in adult human hematopoiesis Save
- Supplemental Figure S1 from Reprogramming Cancer into Antigen Presenting Cells as a Novel Immunotherapy Save
- Supplemental Figure S1 from Reprogramming Cancer into Antigen Presenting Cells as a Novel Immunotherapy Save
- Supplemental Figure S10 from Reprogramming Cancer into Antigen Presenting Cells as a Novel Immunotherapy Save
- Supplemental Figure S10 from Reprogramming Cancer into Antigen Presenting Cells as a Novel Immunotherapy Save
- Supplemental Figure S2 from Reprogramming Cancer into Antigen Presenting Cells as a Novel Immunotherapy Save